Ameritas Investment Partners’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$127K	Hold	6,486	–	–	﹤0.01%	1540
2025 Q4	$202K	Buy	6,486 +621	+11%	+$17K	0.01%	1253
2025 Q3	$127K	Sell	5,865 -1,228	-17%	-$22.1K	﹤0.01%	1539
2025 Q2	$99.2K	Sell	7,093 -553	-7%	-$7.5K	﹤0.01%	1766
2025 Q1	$103K	Hold	7,646	–	–	﹤0.01%	1682
2024 Q4	$147K	Buy	7,646 +1,516	+25%	+$33K	﹤0.01%	1519
2024 Q3	$139K	Hold	6,130	–	–	﹤0.01%	1572
2024 Q2	$79.8K	Buy	6,130 +1,169	+24%	+$16.2K	﹤0.01%	1871
2024 Q1	$86.9K	Buy	4,961 +799	+19%	+$15.5K	﹤0.01%	1826
2023 Q4	$90.6K	Hold	4,162	–	–	﹤0.01%	1806
2023 Q3	$63.8K	Buy	4,162 +677	+19%	+$12.9K	﹤0.01%	1950
2023 Q2	$82.9K	Buy	3,485 +459	+15%	+$11.8K	﹤0.01%	1722
2023 Q1	$77K	Hold	3,026	–	–	﹤0.01%	1701
2022 Q4	$108K	Buy	3,026 +1,091	+56%	+$25.1K	﹤0.01%	1537
2022 Q3	$39K	Hold	1,935	–	–	﹤0.01%	2159
2022 Q2	$22K	Buy	+1,935	New	+$26K	﹤0.01%	2516
2019 Q2	–	Sell	-74	Closed	-$3K	–	3108
2019 Q1	$3K	Hold	74	–	–	﹤0.01%	2923
2018 Q4	$3K	Hold	74	–	–	﹤0.01%	2920
2018 Q3	$6K	Hold	74	–	–	﹤0.01%	2934
2018 Q2	$7K	Hold	74	–	–	﹤0.01%	2905
2018 Q1	$8K	Buy	+74	New	+$8.04K	﹤0.01%	2795